Christopher S. Deppe
Known title: Chief Financial OfficerCIK: 0002113658
Associated companies
Transaction History
| CHWY | ▼ Sell | Tax Withholding | 1,541 | $37K | 9/1/2026 | View on chart |
| CHWY | ▼ Sell | Tax Withholding | 624 | $14K | 7/31/2026 | View on chart |
| CHWY | ▼ Sell | Tax Withholding | 182 | $4K | 6/1/2026 | View on chart |
| CHWY | ▼ Sell | Tax Withholding | 2,857 | $73K | 5/1/2026 | View on chart |
| CHWY | ▲ Buy | Grant | 71,062 | $0 | 4/8/2026 | View on chart |
| CHWY | ▲ Buy | Grant | 346,670 | $0 | 4/8/2026 | View on chart |
| CHWY | ▲ Buy | Grant | 5,922 | $0 | 4/8/2026 | View on chart |
| CHWY | ▲ Buy | Grant | 4,342 | $0 | 3/25/2026 | View on chart |
| CHWY | ▼ Sell | Open Market | 3,043 | $82K | 3/2/2026 | View on chart |
| CHWY | ▼ Sell | Tax Withholding | 1,976 | $53K | 2/27/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Chewy vet care growth offsets Mizuho price target cut
Chewy reported triple-digit growth in its vet care segment as clinic scale builds. Meanwhile, Mizuho maintained an Outperform rating but lowered its price target to $28. The stock currently trades near its 52-week low, reflecting mixed sentiment despite positive operational updates.
Chewy vet care growth offsets Mizuho price target cut. Chewy reported triple-digit growth in its vet care segment as clinic scale builds. Meanwhile, Mizuho maintained an Outperform rating but lowered its price target to $28. The stock currently trades near its 52-week low, reflecting mixed sentiment despite positive operational updates.